nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PTGS2—thyroid cancer	0.418	1	CbGaD
Tetrahydrobiopterin—NOS3—Doxorubicin—thyroid cancer	0.397	1	CbGbCtD
Tetrahydrobiopterin—Oesophageal pain—Sorafenib—thyroid cancer	0.0204	0.244	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.00266	0.0306	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—neck—thyroid cancer	0.00243	0.173	CbGeAlD
Tetrahydrobiopterin—TPH1—head—thyroid cancer	0.00239	0.171	CbGeAlD
Tetrahydrobiopterin—Respiratory failure—Vandetanib—thyroid cancer	0.00222	0.0266	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00217	0.025	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00202	0.0232	CbGpPWpGaD
Tetrahydrobiopterin—PAH—head—thyroid cancer	0.00188	0.134	CbGeAlD
Tetrahydrobiopterin—Rhinorrhoea—Sorafenib—thyroid cancer	0.00182	0.0217	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—NKX2-1—thyroid cancer	0.00172	0.0199	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00159	0.0183	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.00158	0.0189	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—thyroid cancer	0.00158	0.0183	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00147	0.017	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—trachea—thyroid cancer	0.00146	0.104	CbGeAlD
Tetrahydrobiopterin—PTGS2—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.00144	0.0166	CbGpPWpGaD
Tetrahydrobiopterin—Nasopharyngitis—Vandetanib—thyroid cancer	0.00142	0.0169	CcSEcCtD
Tetrahydrobiopterin—NOS3—Endothelin Pathways—CALCA—thyroid cancer	0.00141	0.0162	CbGpPWpGaD
Tetrahydrobiopterin—Gastritis—Vandetanib—thyroid cancer	0.0014	0.0168	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00134	0.0154	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Vandetanib—thyroid cancer	0.00128	0.0153	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00127	0.0152	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00125	0.0144	CbGpPWpGaD
Tetrahydrobiopterin—Infestation—Vandetanib—thyroid cancer	0.00122	0.0146	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Vandetanib—thyroid cancer	0.00122	0.0146	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—NDUFA13—thyroid cancer	0.00121	0.0139	CbGpPWpGaD
Tetrahydrobiopterin—Urinary tract infection—Vandetanib—thyroid cancer	0.00119	0.0142	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00116	0.0134	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—thyroid gland—thyroid cancer	0.00116	0.0825	CbGeAlD
Tetrahydrobiopterin—TH—head—thyroid cancer	0.00114	0.0813	CbGeAlD
Tetrahydrobiopterin—NOS3—Angiogenesis—HIF1A—thyroid cancer	0.00113	0.0131	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—LGALS3—thyroid cancer	0.00107	0.0123	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00106	0.0122	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—head—thyroid cancer	0.00102	0.0732	CbGeAlD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—CDK1—thyroid cancer	0.00101	0.0116	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—NKX2-1—thyroid cancer	0.000991	0.0114	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Vandetanib—thyroid cancer	0.000988	0.0118	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000979	0.0113	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain upper—Sorafenib—thyroid cancer	0.000976	0.0117	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFR1 specific signals—HIF1A—thyroid cancer	0.000973	0.0112	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000959	0.0111	CbGpPWpGaD
Tetrahydrobiopterin—Nasopharyngitis—Sorafenib—thyroid cancer	0.000956	0.0114	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Vandetanib—thyroid cancer	0.000954	0.0114	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Sorafenib—thyroid cancer	0.000946	0.0113	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000938	0.0108	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.000878	0.0101	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Sorafenib—thyroid cancer	0.000864	0.0103	CcSEcCtD
Tetrahydrobiopterin—NOS3—eNOS activation—AKT1—thyroid cancer	0.000834	0.00962	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Vandetanib—thyroid cancer	0.000833	0.00995	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Vandetanib—thyroid cancer	0.000827	0.00988	CcSEcCtD
Tetrahydrobiopterin—Infestation—Sorafenib—thyroid cancer	0.000824	0.00985	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Sorafenib—thyroid cancer	0.000824	0.00985	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Vandetanib—thyroid cancer	0.000812	0.00971	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000812	0.00971	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Sorafenib—thyroid cancer	0.000807	0.00965	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.000807	0.00965	CcSEcCtD
Tetrahydrobiopterin—TH—lymph node—thyroid cancer	0.000798	0.0569	CbGeAlD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000774	0.00893	CbGpPWpGaD
Tetrahydrobiopterin—Infection—Vandetanib—thyroid cancer	0.000774	0.00925	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000769	0.00887	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Vandetanib—thyroid cancer	0.000764	0.00913	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Vandetanib—thyroid cancer	0.000756	0.00904	CcSEcCtD
Tetrahydrobiopterin—NOS3—lymph node—thyroid cancer	0.000718	0.0512	CbGeAlD
Tetrahydrobiopterin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00071	0.00848	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—HIF1A—thyroid cancer	0.000693	0.008	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Vandetanib—thyroid cancer	0.000686	0.0082	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000672	0.00804	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Sorafenib—thyroid cancer	0.000666	0.00797	CcSEcCtD
Tetrahydrobiopterin—NOS3—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—thyroid cancer	0.000662	0.00764	CbGpPWpGaD
Tetrahydrobiopterin—Malnutrition—Sorafenib—thyroid cancer	0.000644	0.0077	CcSEcCtD
Tetrahydrobiopterin—PAH—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.000642	0.0074	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000637	0.00761	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000636	0.00733	CbGpPWpGaD
Tetrahydrobiopterin—Cardiovascular disorder—Epirubicin—thyroid cancer	0.000619	0.0074	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Vandetanib—thyroid cancer	0.000616	0.00736	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Vandetanib—thyroid cancer	0.000616	0.00736	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000608	0.00701	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—MINPP1—thyroid cancer	0.000582	0.00671	CbGpPWpGaD
Tetrahydrobiopterin—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.000573	0.00685	CcSEcCtD
Tetrahydrobiopterin—Cough—Sorafenib—thyroid cancer	0.000562	0.00672	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Sorafenib—thyroid cancer	0.000548	0.00655	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000544	0.00651	CcSEcCtD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—PRKAR1A—thyroid cancer	0.000536	0.00618	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Vandetanib—thyroid cancer	0.000533	0.00637	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Sorafenib—thyroid cancer	0.000525	0.00628	CcSEcCtD
Tetrahydrobiopterin—Infection—Sorafenib—thyroid cancer	0.000522	0.00624	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Sorafenib—thyroid cancer	0.000515	0.00616	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Vandetanib—thyroid cancer	0.000515	0.00616	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Sorafenib—thyroid cancer	0.00051	0.0061	CcSEcCtD
Tetrahydrobiopterin—TH—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.000504	0.00581	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—HIF1A—thyroid cancer	0.000504	0.00581	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—CDK1—thyroid cancer	0.000497	0.00573	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Vandetanib—thyroid cancer	0.000495	0.00592	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—NDUFA13—thyroid cancer	0.000495	0.00571	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Vandetanib—thyroid cancer	0.000491	0.00587	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Vandetanib—thyroid cancer	0.000491	0.00587	CcSEcCtD
Tetrahydrobiopterin—Headache—Vandetanib—thyroid cancer	0.000488	0.00583	CcSEcCtD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—thyroid cancer	0.000484	0.00558	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—CCND1—thyroid cancer	0.00048	0.00554	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000479	0.00572	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—CDK1—thyroid cancer	0.000469	0.00541	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—CHST14—thyroid cancer	0.000465	0.00536	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000465	0.00536	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—trachea—thyroid cancer	0.000463	0.033	CbGeAlD
Tetrahydrobiopterin—Nausea—Vandetanib—thyroid cancer	0.000463	0.00553	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Sorafenib—thyroid cancer	0.000462	0.00553	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism of nitric oxide—AKT1—thyroid cancer	0.000459	0.00529	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000454	0.00542	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—PPARG—thyroid cancer	0.000441	0.00509	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TRIM24—thyroid cancer	0.000432	0.00498	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00043	0.00514	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—MINPP1—thyroid cancer	0.000425	0.00491	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—CCND1—thyroid cancer	0.000419	0.00483	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Sorafenib—thyroid cancer	0.000415	0.00496	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Sorafenib—thyroid cancer	0.000415	0.00496	CcSEcCtD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—CALCA—thyroid cancer	0.000408	0.0047	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—thyroid cancer	0.000407	0.0047	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CHST14—thyroid cancer	0.000406	0.00468	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—PTEN—thyroid cancer	0.000404	0.00466	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000395	0.00472	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Sorafenib—thyroid cancer	0.000387	0.00463	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—TRIM33—thyroid cancer	0.000385	0.00444	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—NRAS—thyroid cancer	0.000384	0.00443	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiogenesis—AKT1—thyroid cancer	0.00038	0.00439	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—HPGD—thyroid cancer	0.000375	0.00432	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000366	0.00437	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000365	0.00421	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—NDUFA13—thyroid cancer	0.000362	0.00417	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain upper—Epirubicin—thyroid cancer	0.000361	0.00431	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Sorafenib—thyroid cancer	0.000359	0.0043	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000353	0.00422	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Epirubicin—thyroid cancer	0.00035	0.00418	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Sorafenib—thyroid cancer	0.000347	0.00415	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—CHST14—thyroid cancer	0.00034	0.00392	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFR2 mediated vascular permeability—AKT1—thyroid cancer	0.000336	0.00388	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—MINPP1—thyroid cancer	0.000334	0.00385	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Sorafenib—thyroid cancer	0.000334	0.00399	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000334	0.00399	CcSEcCtD
Tetrahydrobiopterin—Rash—Sorafenib—thyroid cancer	0.000331	0.00396	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Sorafenib—thyroid cancer	0.000331	0.00396	CcSEcCtD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.00033	0.00381	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Sorafenib—thyroid cancer	0.000329	0.00393	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFR1 specific signals—AKT1—thyroid cancer	0.000327	0.00377	CbGpPWpGaD
Tetrahydrobiopterin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000327	0.00391	CcSEcCtD
Tetrahydrobiopterin—PTGS2—head—thyroid cancer	0.000325	0.0232	CbGeAlD
Tetrahydrobiopterin—Gastritis—Doxorubicin—thyroid cancer	0.000323	0.00387	CcSEcCtD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—BRAF—thyroid cancer	0.00032	0.00369	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Epirubicin—thyroid cancer	0.000319	0.00382	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000317	0.00379	CcSEcCtD
Tetrahydrobiopterin—Nausea—Sorafenib—thyroid cancer	0.000312	0.00373	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Epirubicin—thyroid cancer	0.000304	0.00364	CcSEcCtD
Tetrahydrobiopterin—Infestation—Epirubicin—thyroid cancer	0.000304	0.00364	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—PTEN—thyroid cancer	0.000303	0.00349	CbGpPWpGaD
Tetrahydrobiopterin—Urinary tract infection—Epirubicin—thyroid cancer	0.000296	0.00354	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Doxorubicin—thyroid cancer	0.000295	0.00353	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000294	0.00351	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—NRAS—thyroid cancer	0.000291	0.00335	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NDUFA13—thyroid cancer	0.000284	0.00328	CbGpPWpGaD
Tetrahydrobiopterin—Infestation NOS—Doxorubicin—thyroid cancer	0.000282	0.00337	CcSEcCtD
Tetrahydrobiopterin—Infestation—Doxorubicin—thyroid cancer	0.000282	0.00337	CcSEcCtD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.000281	0.00324	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—TP53—thyroid cancer	0.000276	0.00318	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—CCND1—thyroid cancer	0.000275	0.00317	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—LGALS3—thyroid cancer	0.000275	0.00317	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—HPGD—thyroid cancer	0.000274	0.00316	CbGpPWpGaD
Tetrahydrobiopterin—Urinary tract infection—Doxorubicin—thyroid cancer	0.000274	0.00327	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Epirubicin—thyroid cancer	0.000271	0.00324	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Epirubicin—thyroid cancer	0.000269	0.00322	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—CHST14—thyroid cancer	0.000267	0.00308	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TCF7L1—thyroid cancer	0.000257	0.00296	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—PPARG—thyroid cancer	0.000254	0.00292	CbGpPWpGaD
Tetrahydrobiopterin—Pharyngitis—Doxorubicin—thyroid cancer	0.000251	0.003	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—KRAS—thyroid cancer	0.00025	0.00289	CbGpPWpGaD
Tetrahydrobiopterin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000249	0.00298	CcSEcCtD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.000248	0.00286	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Epirubicin—thyroid cancer	0.000246	0.00294	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Epirubicin—thyroid cancer	0.000238	0.00284	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—TRIM24—thyroid cancer	0.000235	0.00271	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—MINPP1—thyroid cancer	0.000232	0.00267	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000228	0.00272	CcSEcCtD
Tetrahydrobiopterin—PTGS2—lymph node—thyroid cancer	0.000227	0.0162	CbGeAlD
Tetrahydrobiopterin—NOS3—Disease—CHST14—thyroid cancer	0.000221	0.00255	CbGpPWpGaD
Tetrahydrobiopterin—Malnutrition—Doxorubicin—thyroid cancer	0.00022	0.00263	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—thyroid cancer	0.000219	0.00252	CbGpPWpGaD
Tetrahydrobiopterin—Agitation—Epirubicin—thyroid cancer	0.000219	0.00261	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—TPR—thyroid cancer	0.000215	0.00248	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—HPGD—thyroid cancer	0.000215	0.00248	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—HRAS—thyroid cancer	0.000213	0.00245	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PRKAR1A—thyroid cancer	0.000212	0.00244	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—AKT1—thyroid cancer	0.000211	0.00244	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TRIM33—thyroid cancer	0.00021	0.00242	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PRKAR1A—thyroid cancer	0.000208	0.0024	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Epirubicin—thyroid cancer	0.000208	0.00248	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—TP53—thyroid cancer	0.000207	0.00238	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Epirubicin—thyroid cancer	0.000206	0.00246	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—BRAF—thyroid cancer	0.000203	0.00235	CbGpPWpGaD
Tetrahydrobiopterin—Arthralgia—Epirubicin—thyroid cancer	0.000203	0.00242	CcSEcCtD
Tetrahydrobiopterin—Agitation—Doxorubicin—thyroid cancer	0.000202	0.00242	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000201	0.0024	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—NDUFA13—thyroid cancer	0.000197	0.00227	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000194	0.00232	CcSEcCtD
Tetrahydrobiopterin—NOS3—Thromboxane A2 receptor signaling—AKT1—thyroid cancer	0.000193	0.00223	CbGpPWpGaD
Tetrahydrobiopterin—Infection—Epirubicin—thyroid cancer	0.000193	0.00231	CcSEcCtD
Tetrahydrobiopterin—Cough—Doxorubicin—thyroid cancer	0.000192	0.0023	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Doxorubicin—thyroid cancer	0.000191	0.00228	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Epirubicin—thyroid cancer	0.00019	0.00228	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Epirubicin—thyroid cancer	0.000189	0.00225	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—TPR—thyroid cancer	0.000188	0.00217	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CDK1—thyroid cancer	0.000188	0.00217	CbGpPWpGaD
Tetrahydrobiopterin—Arthralgia—Doxorubicin—thyroid cancer	0.000187	0.00224	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000186	0.00222	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—CHST14—thyroid cancer	0.000185	0.00214	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PRKAR1A—thyroid cancer	0.000185	0.00213	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00018	0.00215	CcSEcCtD
Tetrahydrobiopterin—Infection—Doxorubicin—thyroid cancer	0.000178	0.00213	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—NRAS—thyroid cancer	0.000178	0.00205	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000177	0.00211	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—MEN1—thyroid cancer	0.000177	0.00204	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Doxorubicin—thyroid cancer	0.000176	0.00211	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Doxorubicin—thyroid cancer	0.000174	0.00209	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—PTEN—thyroid cancer	0.000174	0.00201	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—HRAS—thyroid cancer	0.000173	0.002	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Epirubicin—thyroid cancer	0.000171	0.00204	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—AKT1—thyroid cancer	0.000169	0.00195	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—NRAS—thyroid cancer	0.000168	0.00194	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000168	0.002	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thyroid cancer	0.000165	0.00191	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000164	0.00196	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—SLC5A5—thyroid cancer	0.000161	0.00186	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000159	0.0019	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Doxorubicin—thyroid cancer	0.000158	0.00189	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—TPR—thyroid cancer	0.000157	0.00182	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000155	0.00185	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—PRKAR1A—thyroid cancer	0.000155	0.00179	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CALCB—thyroid cancer	0.000155	0.00179	CbGpPWpGaD
Tetrahydrobiopterin—Body temperature increased—Epirubicin—thyroid cancer	0.000153	0.00183	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Epirubicin—thyroid cancer	0.000153	0.00183	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—KRAS—thyroid cancer	0.000153	0.00177	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—AKT1—thyroid cancer	0.000153	0.00176	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—HPGD—thyroid cancer	0.000149	0.00172	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000147	0.00176	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TRIM33—thyroid cancer	0.000147	0.00169	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—KRAS—thyroid cancer	0.000145	0.00167	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—PTEN—thyroid cancer	0.000143	0.00165	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000143	0.00165	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Epirubicin—thyroid cancer	0.000143	0.00171	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Doxorubicin—thyroid cancer	0.000142	0.0017	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Doxorubicin—thyroid cancer	0.000142	0.0017	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—CALCA—thyroid cancer	0.000141	0.00162	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TCF7L1—thyroid cancer	0.00014	0.00161	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—IFNA2—thyroid cancer	0.000138	0.00159	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000137	0.00158	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000136	0.00157	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—RXRA—thyroid cancer	0.000135	0.00156	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Epirubicin—thyroid cancer	0.000133	0.00159	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000132	0.00158	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—HRAS—thyroid cancer	0.00013	0.0015	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.00013	0.0015	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Epirubicin—thyroid cancer	0.000128	0.00153	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—CDK1—thyroid cancer	0.000127	0.00147	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—TPR—thyroid cancer	0.000124	0.00143	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Epirubicin—thyroid cancer	0.000123	0.00148	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000123	0.00142	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—HRAS—thyroid cancer	0.000123	0.00142	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Doxorubicin—thyroid cancer	0.000123	0.00147	CcSEcCtD
Tetrahydrobiopterin—Rash—Epirubicin—thyroid cancer	0.000122	0.00146	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Epirubicin—thyroid cancer	0.000122	0.00146	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—PRKAR1A—thyroid cancer	0.000122	0.0014	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Epirubicin—thyroid cancer	0.000122	0.00145	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Doxorubicin—thyroid cancer	0.000119	0.00142	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—TP53—thyroid cancer	0.000119	0.00137	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000119	0.00137	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—SLC5A5—thyroid cancer	0.000118	0.00136	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Epirubicin—thyroid cancer	0.000115	0.00138	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—AKT1—thyroid cancer	0.000115	0.00133	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Doxorubicin—thyroid cancer	0.000114	0.00137	CcSEcCtD
Tetrahydrobiopterin—Rash—Doxorubicin—thyroid cancer	0.000113	0.00135	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Doxorubicin—thyroid cancer	0.000113	0.00135	CcSEcCtD
Tetrahydrobiopterin—Headache—Doxorubicin—thyroid cancer	0.000113	0.00135	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—KRAS—thyroid cancer	0.00011	0.00127	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—AKT1—thyroid cancer	0.000109	0.00125	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Doxorubicin—thyroid cancer	0.000107	0.00128	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000105	0.00121	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	0.000103	0.00118	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TPR—thyroid cancer	0.000102	0.00118	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NRG1—thyroid cancer	0.000102	0.00118	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PRKAR1A—thyroid cancer	0.000101	0.00116	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—RXRA—thyroid cancer	9.9e-05	0.00114	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TCF7L1—thyroid cancer	9.79e-05	0.00113	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MEN1—thyroid cancer	9.62e-05	0.00111	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TRIM24—thyroid cancer	9.62e-05	0.00111	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MINPP1—thyroid cancer	9.47e-05	0.00109	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—HRAS—thyroid cancer	9.35e-05	0.00108	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—SLC5A5—thyroid cancer	9.26e-05	0.00107	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TERT—thyroid cancer	9.18e-05	0.00106	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CHST14—thyroid cancer	9.04e-05	0.00104	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	8.84e-05	0.00102	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HIF1A—thyroid cancer	8.78e-05	0.00101	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—TPR—thyroid cancer	8.57e-05	0.000989	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TRIM33—thyroid cancer	8.57e-05	0.000989	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PPARG—thyroid cancer	8.55e-05	0.000986	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PRKAR1A—thyroid cancer	8.43e-05	0.000973	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—AKT1—thyroid cancer	8.26e-05	0.000952	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NDUFA13—thyroid cancer	8.05e-05	0.000929	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	7.82e-05	0.000902	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—RXRA—thyroid cancer	7.78e-05	0.000897	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CALCA—thyroid cancer	7.66e-05	0.000884	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	7.61e-05	0.000877	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CHST14—thyroid cancer	7.57e-05	0.000873	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—BRAF—thyroid cancer	7.27e-05	0.000839	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TSHR—thyroid cancer	7.17e-05	0.000827	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PRKAR1A—thyroid cancer	7.05e-05	0.000813	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDK1—thyroid cancer	6.94e-05	0.0008	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MEN1—thyroid cancer	6.74e-05	0.000777	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PTGS2—thyroid cancer	6.73e-05	0.000776	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	6.47e-05	0.000746	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—SLC5A5—thyroid cancer	6.42e-05	0.00074	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PPARG—thyroid cancer	6.25e-05	0.000721	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HPGD—thyroid cancer	6.1e-05	0.000704	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTCH1—thyroid cancer	6.09e-05	0.000703	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PTGS2—thyroid cancer	5.87e-05	0.000677	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PTEN—thyroid cancer	5.87e-05	0.000677	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TCF7L1—thyroid cancer	5.72e-05	0.00066	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SST—thyroid cancer	5.57e-05	0.000643	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NRG1—thyroid cancer	5.57e-05	0.000642	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—RXRA—thyroid cancer	5.39e-05	0.000622	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CALCA—thyroid cancer	5.37e-05	0.000619	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	5.32e-05	0.000614	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	5.15e-05	0.000594	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—NRAS—thyroid cancer	5.14e-05	0.000593	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	5.14e-05	0.000592	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PTEN—thyroid cancer	5.12e-05	0.000591	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TERT—thyroid cancer	5e-05	0.000577	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.95e-05	0.000571	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTGS2—thyroid cancer	4.92e-05	0.000567	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PPARG—thyroid cancer	4.91e-05	0.000566	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDK1—thyroid cancer	4.86e-05	0.00056	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HIF1A—thyroid cancer	4.78e-05	0.000551	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NRAS—thyroid cancer	4.57e-05	0.000527	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—KRAS—thyroid cancer	4.42e-05	0.00051	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTEN—thyroid cancer	4.29e-05	0.000495	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TPR—thyroid cancer	4.19e-05	0.000483	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PRKAR1A—thyroid cancer	4.12e-05	0.000475	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—BRAF—thyroid cancer	3.96e-05	0.000457	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.94e-05	0.000455	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MEN1—thyroid cancer	3.94e-05	0.000454	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KRAS—thyroid cancer	3.93e-05	0.000454	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—thyroid cancer	3.93e-05	0.000453	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NRG1—thyroid cancer	3.9e-05	0.00045	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—thyroid cancer	3.86e-05	0.000446	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—HRAS—thyroid cancer	3.76e-05	0.000434	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TPR—thyroid cancer	3.51e-05	0.000404	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.51e-05	0.000404	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TERT—thyroid cancer	3.5e-05	0.000404	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PRKAR1A—thyroid cancer	3.45e-05	0.000398	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PPARG—thyroid cancer	3.4e-05	0.000393	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—AKT1—thyroid cancer	3.38e-05	0.00039	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTEN—thyroid cancer	3.37e-05	0.000389	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HIF1A—thyroid cancer	3.35e-05	0.000386	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HRAS—thyroid cancer	3.34e-05	0.000386	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—AKT1—thyroid cancer	3.32e-05	0.000383	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—thyroid cancer	3.2e-05	0.000369	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CALCA—thyroid cancer	3.13e-05	0.000361	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.13e-05	0.000361	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.96e-05	0.000341	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—AKT1—thyroid cancer	2.95e-05	0.00034	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDK1—thyroid cancer	2.84e-05	0.000327	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTEN—thyroid cancer	2.79e-05	0.000322	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—BRAF—thyroid cancer	2.77e-05	0.00032	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—thyroid cancer	2.68e-05	0.000309	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC5A5—thyroid cancer	2.62e-05	0.000303	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NRAS—thyroid cancer	2.49e-05	0.000287	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—AKT1—thyroid cancer	2.47e-05	0.000285	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTEN—thyroid cancer	2.34e-05	0.000269	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NRG1—thyroid cancer	2.28e-05	0.000263	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—RXRA—thyroid cancer	2.2e-05	0.000254	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.14e-05	0.000247	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KRAS—thyroid cancer	2.14e-05	0.000247	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TERT—thyroid cancer	2.04e-05	0.000236	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCND1—thyroid cancer	2.02e-05	0.000233	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HIF1A—thyroid cancer	1.96e-05	0.000225	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTEN—thyroid cancer	1.95e-05	0.000225	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—AKT1—thyroid cancer	1.94e-05	0.000224	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HRAS—thyroid cancer	1.82e-05	0.00021	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NRAS—thyroid cancer	1.74e-05	0.000201	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BRAF—thyroid cancer	1.62e-05	0.000187	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT1—thyroid cancer	1.61e-05	0.000185	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KRAS—thyroid cancer	1.5e-05	0.000173	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPARG—thyroid cancer	1.39e-05	0.000161	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AKT1—thyroid cancer	1.35e-05	0.000155	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—thyroid cancer	1.33e-05	0.000154	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HRAS—thyroid cancer	1.27e-05	0.000147	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PTEN—thyroid cancer	1.14e-05	0.000132	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT1—thyroid cancer	1.13e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NRAS—thyroid cancer	1.02e-05	0.000117	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PTEN—thyroid cancer	9.55e-06	0.00011	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KRAS—thyroid cancer	8.76e-06	0.000101	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HRAS—thyroid cancer	7.44e-06	8.58e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT1—thyroid cancer	6.57e-06	7.58e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKT1—thyroid cancer	5.5e-06	6.35e-05	CbGpPWpGaD
